GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Shan Dong Kexing Bioproducts Co Ltd (SHSE:688136) » Definitions » Cash Ratio

Shan Dong Kexing Bioproducts Co (SHSE:688136) Cash Ratio : 0.71 (As of Mar. 2024)


View and export this data going back to 2020. Start your Free Trial

What is Shan Dong Kexing Bioproducts Co Cash Ratio?

The Cash Ratio measures a company’s ability to meet its short-term obligations with cash and near-cash resources. It is calculated as a company's Cash, Cash Equivalents, Marketable Securities divides by its Total Current Liabilities. Shan Dong Kexing Bioproducts Co's Cash Ratio for the quarter that ended in Mar. 2024 was 0.71.

Shan Dong Kexing Bioproducts Co has a Cash Ratio of 0.71. It indicates that there are more current liabilities than Cash, Cash Equivalents, Marketable Securities, and the company does not have sufficient cash on hand to pay off its short-term debt.

The historical rank and industry rank for Shan Dong Kexing Bioproducts Co's Cash Ratio or its related term are showing as below:

SHSE:688136' s Cash Ratio Range Over the Past 10 Years
Min: 0.13   Med: 1.18   Max: 3.39
Current: 0.71

During the past 7 years, Shan Dong Kexing Bioproducts Co's highest Cash Ratio was 3.39. The lowest was 0.13. And the median was 1.18.

SHSE:688136's Cash Ratio is ranked worse than
78.31% of 1475 companies
in the Biotechnology industry
Industry Median: 3.03 vs SHSE:688136: 0.71

Shan Dong Kexing Bioproducts Co Cash Ratio Historical Data

The historical data trend for Shan Dong Kexing Bioproducts Co's Cash Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Shan Dong Kexing Bioproducts Co Cash Ratio Chart

Shan Dong Kexing Bioproducts Co Annual Data
Trend Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cash Ratio
Get a 7-Day Free Trial 0.34 2.48 1.45 1.46 0.85

Shan Dong Kexing Bioproducts Co Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Cash Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1.65 1.34 0.87 0.85 0.71

Competitive Comparison of Shan Dong Kexing Bioproducts Co's Cash Ratio

For the Biotechnology subindustry, Shan Dong Kexing Bioproducts Co's Cash Ratio, along with its competitors' market caps and Cash Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Shan Dong Kexing Bioproducts Co's Cash Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Shan Dong Kexing Bioproducts Co's Cash Ratio distribution charts can be found below:

* The bar in red indicates where Shan Dong Kexing Bioproducts Co's Cash Ratio falls into.



Shan Dong Kexing Bioproducts Co Cash Ratio Calculation

The Cash Ratio measures a company's ability to meet its short-term obligations with its cash and near-cash resources.

Shan Dong Kexing Bioproducts Co's Cash Ratio for the fiscal year that ended in Dec. 2023 is calculated as:

Cash Ratio (A: Dec. 2023 )=Cash, Cash Equivalents, Marketable Securities/Total Current Liabilities
=568.796/669.995
=0.85

Shan Dong Kexing Bioproducts Co's Cash Ratio for the quarter that ended in Mar. 2024 is calculated as:

Cash Ratio (Q: Mar. 2024 )=Cash, Cash Equivalents, Marketable Securities/Total Current Liabilities
=542.289/766.641
=0.71

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Shan Dong Kexing Bioproducts Co  (SHSE:688136) Cash Ratio Explanation

The cash ratio is more conservative than other liquidity ratios, such as Quick Ratio and Current Ratio, because it only considers a company's most liquid resources. The numerator of cash ratio only considers Cash, Cash Equivalents and marketable securities. Other current assets, such as accounts receivable and inventories, are not included. The rationale is that these assets may require time to be transformed into cash, and the amount of money received is also uncertain.

The cash ratio shows a company’s ability to pay all current liabilities immediately without selling or liquidating other assets. Generally speaking, a higher cash ratio suggests the company has a stronger ability to cover its short-term debt. However, a high cash ratio could also indicate inefficient management: the company is inefficient in making full utilization of cash to invest protential profitable project. It may also suggest that the company is not confident about future profitability.

In general, the higher the cash ratio, the better the company's liquidity position.


Shan Dong Kexing Bioproducts Co Cash Ratio Related Terms

Thank you for viewing the detailed overview of Shan Dong Kexing Bioproducts Co's Cash Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Shan Dong Kexing Bioproducts Co (SHSE:688136) Business Description

Traded in Other Exchanges
N/A
Address
No. 2666, Chuangye Road, Mingshui Development Zone, Zhangqiu District, Shandong Province, Jinan, CHN, 250200
Shan Dong Kexing Bioproducts Co Ltd formerly Kexing Biopharmaceutical Co Ltd is an innovative biopharmaceutical company. It is engaged in the production and sales of recombinant protein drugs and probiotics. The company use the drugs in the fields of antiviral, hematology, tumor and immunity, and degenerative diseases.
Executives
Wang Xiao Qin Directors, senior managers
Cui Ning Directors, senior managers
Ma Hong Jie senior management
Shao Ke senior management
Deng Xue Qin Director
Zhao Yan Qing Directors, senior managers

Shan Dong Kexing Bioproducts Co (SHSE:688136) Headlines

No Headlines